Humidity, Hard Truths, and the Future of Global Health Security
Multisectoral collaboration is a fundamental requirement for stronger health security.
Artificial Intelligence
Rapid advances in AI have significant implications for nuclear and biosecurity, including benefits and risks for nuclear weapons systems and the growing bioeconomy. Managing these new capabilities to ensure they aren’t misused to undermine strategic stability or cause a global biological catastrophe will require coordinated leadership, new guardrails, and innovative policy approaches.
AIxBio Horizon Scan Winter 2025-2026
Past Event
Report Launch: Safeguarding AIxBio Capabilities to Prevent Global Catastrophe
Virtual Report Launch
|
11:00 AM – 12:00 PM ET
Developing Guardrails for AI Biodesign Tools
Eric Schmidt on Global Security in the Age of Artificial Intelligence
The Convergence of Artificial Intelligence and the Life Sciences
Assessing and Managing the Benefits and Risks of Artificial Intelligence in Nuclear-Weapon Systems
Media Coverage
DeepSeek Tests Meta’s Ambition for US Open-Source AI Dominance
Bloomberg
Former US Energy Secretary Moniz Warns on Dangers of AI in Nuclear Weapons Loop
The National
Could AI make the next pandemic deadlier?
Prospect
Nuclear Threat Initiative says urgent steps needed to manage AI dangers
The National News
Projects
Global Catastrophic Biological Risks
Preventing global catastrophic biological risks (GCBRS)
Biosecurity Innovation and Risk Reduction Initiative
Advances in biotechnology outpace national governments’ ability to provide needed oversight to prevent accidents or deliberate misuse of dangerous biological agents.
Past Project Emerging Technology Risks and Rewards for U.S. Nuclear Modernization
For as long as we have nuclear weapons, the United States must ensure they are safe, secure, and reliable.
News & Analysis
NTI, Concordia AI Launch International Working Group to Improve Biological Capability Evaluations
NTI | bio and Concordia AI, with technical input from SecureBio, have launched the AIxBio Technical Working Group on Evaluation Practice. Convened through the AIxBio Global Forum, the Working Group will bring together experts from organizations in China, the European Union, the United Kingdom, and the United States that develop or conduct biological capability evaluations of AI systems.
NTI Engages Senior Congressional Staff with New Congressional Leadership Project (CLP)
A bipartisan, bicameral group of 17 senior congressional staff completed the inaugural edition of NTI’s new Congressional Leadership Project.
NTI | bio Engages Global Leaders at GHS2026 in Kuala Lumpur
NTI | bio experts will take part in several GHS2026 sessions, including a preview of findings from the forthcoming Africa Health Security (AHS) Index and a timely discussion on strengthening health security partnerships amid declining resources.
AIxBio Horizon Scan: Spring 2026
Since the AIxBio Horizon Scan Winter 2025-2026 published in March 2026, there has been steady, incremental progress across AI-enabled biological tools. Protein design tools have continued to improve, agentic coding tools have matured in ways that lower barriers to computational biology, and commercial AI companies are making significant investments in the life sciences.
NTI CEO Christine Wormuth on Opportunities to Strengthen Security Through Cooperation at the Trump-Xi Summit
The Summit can produce outcomes that strengthen U.S. national security and reduce global nuclear and biological risks